| 1 |
陈实．肺移植发展历程[J]．中华器官移植杂志，2022，43（8）：451-455．
|
| 2 |
刘峰，陈静瑜，叶书高，等．民用航空超长距离转运供肺肺移植（附6例报告）[J]．器官移植，2015（6）：374-377．
|
| 3 |
Laubach VE，Sharma AK．Mechanisms of lung ischemia-reperfusion injury[J]．Curr Opin Organ Transplant，2016，21（3）：246-252．
|
| 4 |
Kapnadak SG，Raghu G．Lung transplantation for interstitial lung disease[J]．Eur Respir Rev，2021，30（161）：210017．
|
| 5 |
Sadaf D，Ahmad MZ．Calcium hydroxide (CaOH(2)) as an intracanal medication may significantly reduce endotoxins level from infected teeth[J]．J Evid Based Dent Pract，2021，21（3）：101616．
|
| 6 |
Chambers DC，Cherikh WS，Harhay MO，et al．The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match[J]．J Heart Lung Transplant，2019，38（10）：1042-1055．
|
| 7 |
Swaminathan AC，Todd JL，Palmer SM．Advances in Human Lung Transplantation[J]．Annu Rev Med，2021，72：135-149．
|
| 8 |
Roesel MJ，Sharma NS，Schroeter A，et al．Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury[J]．Front Immunol，2022，13：891564．
|
| 9 |
Li S，Hafeez A，Noorulla F，et al．Preconditioning in neuroprotection: From hypoxia to ischemia[J]．Prog Neurobiol，2017，157：79-91．
|
| 10 |
Cui C，Zhou T，Li J，et al．Proteomic analysis of the mouse brain after repetitive exposure to hypoxia[J]．Chem Biol Interact，2015，236：57-66．
|
| 11 |
Fuhrmann DC，Brüne B．Mitochondrial composition and function under the control of hypoxia[J]．Redox Biol，2017，12：208-215．
|
| 12 |
Pak O，Sydykov A，Kosanovic D，et al．Lung Ischaemia-Reperfusion Injury: The Role of Reactive Oxygen Species[J]．Adv Exp Med Biol，2017，967：195-225．
|
| 13 |
Shi Q，Feng N，Ma Q，et al．ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI[J]．Oxid Med Cell Longev，2022，2022：7288729．
|
| 14 |
Chatterjee S，Nieman GF，Christie JD，et al．Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation[J]．Am J Physiol Lung Cell Mol Physiol，2014，307（9）：L668-L680．
|
| 15 |
Ottolia M，John S，Hazan A，et al．The Cardiac Na(+) -Ca(2+) Exchanger: From Structure to Function[J]．Compr Physiol，2021，12（1）：2681-2717．
|
| 16 |
Hernansanz-Agustín P，Choya-Foces C，Carregal-Romero S，et al．Na(+) controls hypoxic signalling by the mitochondrial respiratory chain[J]．Nature，2020，586（7828）：287-291．
|
| 17 |
Zhang W，Qi Z，Wang Y．BTP2, a Store-Operated Calcium Channel Inhibitor, Attenuates Lung Ischemia-Reperfusion Injury in Rats[J]．Inflammation，2017，40（3）：778-787．
|
| 18 |
Mohamed MS．Calcium-activated potassium channels in ischemia-reperfusion: learning for the clinical application[J]．Front Med (Lausanne)，2015，2：21．
|
| 19 |
Singh S，Mabalirajan U．Mitochondrial calcium in command of juggling myriads of cellular functions[J]．Mitochondrion，2021，57：108-118．
|
| 20 |
Bovo E，Mazurek SR，Zima AV．Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca(2+) waves during β-adrenergic receptor stimulation[J]．Am J Physiol Heart Circ Physiol，2018，315（4）：H1032-H1040．
|
| 21 |
Tan Y，Mui D，Toan S，et al．SERCA Overexpression Improves Mitochondrial Quality Control and Attenuates Cardiac Microvascular Ischemia-Reperfusion Injury[J]．Mol Ther Nucleic Acids，2020，22：696-707．
|
| 22 |
Peng CK，Huang KL，Wu CP，et al．Glutamine protects ischemia-reperfusion induced acute lung injury in isolated rat lungs[J]．Pulm Pharmacol Ther，2011，24（1）：153-161．
|
| 23 |
Li W，Terada Y，Tyurina YY，et al．Necroptosis triggers spatially restricted neutrophil-mediated vascular damage during lung ischemia reperfusion injury[J]．Proc Natl Acad Sci U S A，2022，119（10）：e2111537119．
|
| 24 |
Hashemi P，Nouri-Vaskeh M，Alizadeh L，et al．NETosis in ischemic/reperfusion injuries: An organ-based review[J]．Life Sci，2022，290：120158．
|
| 25 |
Wang JF，Wang YP，Xie J，et al．Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis[J]．Blood，2021，138（9）：806-810．
|
| 26 |
Livingston MJ，Wang J，Zhou J，et al．Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys[J]．Autophagy，2019，15（12）：2142-2162．
|
| 27 |
Tang B，Luo Z，Zhang R，et al．An update on the molecular mechanism and pharmacological interventions for Ischemia-reperfusion injury by regulating AMPK/mTOR signaling pathway in autophagy[J]．Cell Signal，2023，107：110665．
|
| 28 |
Zhan Y，Ling Y，Deng Q，et al．HMGB1-Mediated Neutrophil Extracellular Trap Formation Exacerbates Intestinal Ischemia/Reperfusion-Induced Acute Lung Injury[J]．J Immunol，2022，208（4）：968-978．
|
| 29 |
Sayah DM，Mallavia B，Liu F，et al．Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation[J]．Am J Respir Crit Care Med，2015，191（4）：455-463．
|
| 30 |
Bonneau S，Landry C，Bégin S，et al．Correlation between Neutrophil Extracellular Traps (NETs) Expression and Primary Graft Dysfunction Following Human Lung Transplantation[J]．Cells，2022，11（21）：3420．
|
| 31 |
Mallavia B，Liu F，Lefrançais E，et al．Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction[J]．Am J Respir Cell Mol Biol，2020，62（3）：364-372．
|
| 32 |
Calabrese DR，Tsao T，Magnen M，et al．NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes[J]．JCI Insight，2022，7（24）：e164603．
|
| 33 |
Wong A，Liu M．Inflammatory responses in lungs from donation after brain death: Mechanisms and potential therapeutic targets[J]．J Heart Lung Transplant，2021，40（9）：890-896．
|
| 34 |
Wong A，Zamel R，Yeung J，et al．Potential therapeutic targets for lung repair during human ex vivo lung perfusion[J]．Eur Respir J，2020，55：1902222．
|
| 35 |
Baciu C，Sage A，Zamel R，et al．Transcriptomic investigation reveals donor-specific gene signatures in human lung transplants[J]．Eur Respir J，2021，57：2000327．
|
| 36 |
Capuzzimati M，Hough O，Liu M．Cell death and ischemia-reperfusion injury in lung transplantation[J]．J Heart Lung Transplant，2022，41（8）：1003-1013．
|
| 37 |
Kanou T，Ohsumi A，Kim H，et al．Inhibition of regulated necrosis attenuates receptor-interacting protein kinase 1-mediated ischemia-reperfusion injury after lung transplantation[J]．J Heart Lung Transplant，2018，37（10）：1261-1270．
|
| 38 |
Wang Y，Dong Z，Zhang Z，et al．Postconditioning with Irisin Attenuates Lung Ischemia/Reperfusion Injury by Suppressing Ferroptosis via Induction of the Nrf2/HO-1 Signal Axis[J]．Oxid Med Cell Longev，2022，2022：9911167．
|
| 39 |
Liu WC，Chen SB，Liu S，et al．Inhibition of mitochondrial autophagy protects donor lungs for lung transplantation against ischaemia-reperfusion injury in rats via the mTOR pathway[J]．J Cell Mol Med，2019，23（5）：3190-3201．
|
| 40 |
Park E，Chung SW．ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation[J]．Cell Death Dis，2019，10（11）：822．
|
| 41 |
毛文君，陈静瑜，郑明峰，等．公民逝世后器官捐献供肺移植242例的临床疗效分析[J]．中华器官移植杂志，2017，38（11）：676-681．
|
| 42 |
Sef D，Verzelloni Sef A，Mohite P，et al．Utilization of extracorporeal membrane oxygenation in DCD and DBD lung transplants: a 2-year single-center experience[J]．Transpl Int，2020，33（12）：1788-1798．
|
| 43 |
Porteous MK，Diamond JM，Christie JD．Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation[J]．Curr Opin Organ Transplant，2015，20（5）：506-514．
|
| 44 |
Haverich A，Aziz S，Scott WC，et al．Improved lung preservation using Euro-Collins solution for flush-perfusion[J]．Thorac Cardiovasc Surg，1986，34（6）：368-376．
|
| 45 |
Hausen B，Beuke M，Schroeder F，et al．In vivo measurement of lung preservation solution efficacy: comparison of LPD, UW, EC and low K+-EC following short and extended ischemia[J]．Eur J Cardiothorac Surg，1997，12（5）：771-779；discussion 779-780．
|
| 46 |
Ikeda M，Bando T，Yamada T，et al．Clinical application of ET-Kyoto solution for lung transplantation[J]．Surg Today，2015，45（4）：439-443．
|
| 47 |
Van De Wauwer C，Neyrinck AP，Rega FR，et al．Retrograde flush is more protective than heparin in the uncontrolled donation after circulatory death lung donor[J]．J Surg Res，2014，187（1）：316-323．
|
| 48 |
Saren G，Wong A，Lu YB，et al．Ischemia-Reperfusion Injury in a Simulated Lung Transplant Setting Differentially Regulates Transcriptomic Profiles between Human Lung Endothelial and Epithelial Cells[J]．Cells，2021，10（10）：2713．
|
| 49 |
Beer A，Reed RM，Bölükbas S，et al．Mechanical ventilation after lung transplantation. An international survey of practices and preferences[J]．Ann Am Thorac Soc，2014，11（4）：546-553．
|
| 50 |
Hoetzenecker K，Benazzo A，Stork T，et al．Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: An observational study[J]．J Thorac Cardiovasc Surg，2020，160（1）：320-327.e1．
|
| 51 |
Nathan SD．The future of lung transplantation[J]．Chest，2015，147（2）：309-316．
|
| 52 |
Steen S，Sjöberg T，Pierre L，et al．Transplantation of lungs from a non-heart-beating donor[J]．Lancet，2001，357（9259）：825-829．
|
| 53 |
Warnecke G，Moradiellos J，Tudorache I，et al．Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients[J]．Lancet，2012，380（9856）：1851-1858．
|
| 54 |
Cypel M，Yeung JC，Donahoe L，et al．Normothermic ex vivo lung perfusion: Does the indication impact organ utilization and patient outcomes after transplantation?[J]．J Thorac Cardiovasc Surg，2020，159（1）：346-355.e1．
|
| 55 |
Tian D，Wang Y，Shiiya H，et al．Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis[J]．J Thorac Cardiovasc Surg，2020，159（2）：720-730.e6．
|
| 56 |
Luo Q，Zhu L，Wang Y，et al．The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis[J]．Ann Transplant，2019，24：647-660．
|
| 57 |
Wang A，Ali A，Keshavjee S，et al．Ex vivo lung perfusion for donor lung assessment and repair: a review of translational interspecies models[J]．Am J Physiol Lung Cell Mol Physiol，2020，319（6）：L932-L940．
|
| 58 |
Cypel M，Yeung JC，Hirayama S，et al．Technique for prolonged normothermic ex vivo lung perfusion[J]．J Heart Lung Transplant，2008，27（12）：1319-1325．
|
| 59 |
Lonati C，Bassani GA，Brambilla D，et al．Influence of ex vivo perfusion on the biomolecular profile of rat lungs[J]．FASEB J，2018，32（10）：5532-5549．
|
| 60 |
Chen F，Nakamura T，Fujinaga T，et al．Protective effect of a nebulized beta2-adrenoreceptor agonist in warm ischemic-reperfused rat lungs[J]．Ann Thorac Surg，2006，82（2）：465-471．
|
| 61 |
Yamada T，Chen F，Sakamoto J，et al．Impact of the cardiac arrest mode on cardiac death donor lungs[J]．J Surg Res，2015，195（2）：596-603．
|
| 62 |
Kermeen FD，McNeil KD，Fraser JF，et al．Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant[J]．J Heart Lung Transplant，2007，26（8）：850-856．
|
| 63 |
Ohsumi A，Chen F，Sakamoto J，et al．Protective effect of pre-recovery surfactant inhalation on lungs donated after cardiac death in a canine lung transplantation model[J]．J Heart Lung Transplant，2012，31（10）：1136-1142．
|
| 64 |
Valenza F，Rosso L，Coppola S，et al．β-adrenergic agonist infusion during extracorporeal lung perfusion: effects on glucose concentration in the perfusion fluid and on lung function[J]．J Heart Lung Transplant，2012，31（5）：524-530．
|
| 65 |
Sakamoto J，Chen F，Nakajima D，et al．The effect of β-2 adrenoreceptor agonist inhalation on lungs donated after cardiac death in a canine lung transplantation model[J]．J Heart Lung Transplant，2012，31（7）：773-779．
|
| 66 |
Wu JX，Zhu HW，Chen X，et al．Inducible nitric oxide synthase inhibition reverses pulmonary arterial dysfunction in lung transplantation[J]．Inflamm Res，2014，63（8）：609-618．
|
| 67 |
Meade MO，Granton JT，Matte-Martyn A，et al．A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation[J]．Am J Respir Crit Care Med，2003，167（11）：1483-1489．
|
| 68 |
Ryter SW，Choi AM．Carbon monoxide: present and future indications for a medical gas[J]．Korean J Intern Med，2013，28（2）：123-140．
|
| 69 |
Akhtar MZ，Sutherland AI，Huang H，et al．The role of hypoxia-inducible factors in organ donation and transplantation: the current perspective and future opportunities[J]．Am J Transplant，2014，14（7）：1481-1487．
|
| 70 |
Ohsawa I，Ishikawa M，Takahashi K，et al．Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals[J]．Nat Med，2007，13（6）：688-694．
|
| 71 |
Haam S，Lee S，Paik HC，et al．The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death[J]．Eur J Cardiothorac Surg，2015，48（4）：542-547．
|
| 72 |
Liu H，Liang X，Wang D，et al．Combination therapy with nitric oxide and molecular hydrogen in a murine model of acute lung injury[J]．Shock，2015，43（5）：504-511．
|
| 73 |
Takahashi M，Chen-Yoshikawa TF，Saito M，et al．Immersing lungs in hydrogen-rich saline attenuates lung ischaemia-reperfusion injury[J]．Eur J Cardiothorac Surg，2017，51（3）：442-448．
|
| 74 |
Chen-Yoshikawa TF．Ischemia-Reperfusion Injury in Lung Transplantation[J]．Cells，2021，10（6）：1333．
|
| 75 |
Motoyama H，Chen F，Ohsumi A，et al．Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model[J]．J Heart Lung Transplant，2013，32（5）：505-510．
|
| 76 |
Tian W，Liu Y，Zhang B，et al．Infusion of mesenchymal stem cells protects lung transplants from cold ischemia-reperfusion injury in mice[J]．Lung，2015，193（1）：85-95．
|
| 77 |
Stone ML，Zhao Y，Robert Smith J，et al．Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death[J]．Respir Res，2017，18（1）：212．
|
| 78 |
Antunes MA，Laffey JG，Pelosi P，et al．Mesenchymal stem cell trials for pulmonary diseases[J]．J Cell Biochem，2014，115（6）：1023-1032．
|
| 79 |
Nakajima D，Watanabe Y，Ohsumi A，et al．Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation[J]．J Heart Lung Transplant，2019，38（11）：1214-1223．
|
| 80 |
Matthay MA，Calfee CS，Zhuo H，et al．Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial[J]．Lancet Respir Med，2019，7（2）：154-162．
|
| 81 |
Chambers DC，Enever D，Lawrence S，et al．Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study[J]．Stem Cells Transl Med，2017，6（4）：1152-1157．
|